Omada Health, Inc.
OMDA
Positions held
Your positionsOMDA isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.
- Omada Health operates in a growing healthcare sector focused on digital health solutions, which are increasingly in demand as more patients seek remote care options.
- In Q2 2026, Omada Health reported a revenue increase of 13% compared to the previous quarter, reaching $87.835 million.
- The gross margin improved to 72.6% in Q2 2026, up from 62.4% in Q1 2026.
- Despite growth, Omada Health has faced significant operating losses, indicating challenges in achieving profitability.
- In 2025, the company reported a net income loss of $12.778 million, with an operating margin of -4.6%.
- The trailing P/E ratio stands at 86.375, suggesting that the stock may be overvalued relative to its earnings potential.
Fundamentals
| Market cap | $1.27B | Enterprise value | $1.05B | Trailing P/E | 86.75 | Forward P/E | 37.44 |
| PEG | — | Price / book | 4.99 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 43.1% | Earnings growth | — | Gross margin | 68.2% | Operating margin | 4.0% |
| Profit margin | 1.4% | ROE | 1.8% | ROA | -0.1% | Debt / equity | — |
| Current ratio | 3.91 | Free cash flow | $11.92M | Analyst recommendation | buy | Mean target | $28.42 |
| 52w high | $26.92 | 52w low | $10.28 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $87.8M | $78.0M | $75.8M | $68.0M | $61.4M | — |
| Op margin | 4.0% | -6.1% | 4.3% | -3.7% | -7.1% | — |
| Net income | $5.3M | -$3.0M | $5.2M | -$3.2M | -$5.3M | — |
| Gross margin | 72.6% | 62.4% | 70.8% | 66.3% | 65.7% | — |
| Gross profit | $63.8M | $48.7M | $53.7M | $45.1M | $40.3M | — |
| Operating income | $3.5M | -$4.8M | $3.3M | -$2.5M | -$4.3M | — |
- Revenue +13% vs prior quarter ($88M vs $78M).
- Gross margin 72.6% (was 62.4% prior quarter).
- Operating margin expanded to 4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $260M | $170M | $123M | $89.2M |
| Op margin | -4.6% | -25.7% | -53.8% | -81.1% |
| Net income | -$12.8M | -$47.1M | -$67.5M | -$72.5M |
| Gross margin | 65.7% | 60.6% | 57.0% | 48.0% |
| Gross profit | $171M | $103M | $70.0M | $42.8M |
| Operating income | -$12.0M | -$43.7M | -$66.0M | -$72.3M |
Headlines — positive tone
• [OK · fundamentals] Omada Health Inc (OMDA) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability ...
News
2026-09-23 · Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
2026-09-14 · Omada Health Insider Sold Shares Worth $327,197, According to a Recent SEC Filing
2026-09-10 · Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
2026-09-09 · Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares
2026-09-07 · Here's Why Teladoc's Integrated Care Business Deserves More Attention
2026-08-26 · Earnings To Watch: Omda AS (OSL:OMDA) Q2 2026 -- GF Value Sees 32% Upside
2026-08-13 · Omada Health (OMDA) Q2 2026 Earnings Call Transcript
2026-08-12 · Omada Health Insider Sold Shares Worth $421,547, According to a Recent SEC Filing
2026-08-12 · Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
2026-08-11 · Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
2026-08-09 · Omada Health (OMDA) Could Be 4% Undervalued As Record Earnings Reset The Debate
Price (daily)
Full chart · RSI · MACD · patterns